See the DrugPatentWatch profile for Flecainide
Flecainide 50 mg is a specific dosage of the antiarrhythmic medication flecainide, used to treat certain types of irregular heartbeats [1]. It belongs to the Class Ic antiarrhythmics, which work by blocking sodium channels in the heart, thereby slowing electrical conduction and prolonging the refractory period of heart cells [2]. This action helps to stabilize the heart rhythm [2].
What is Flecainide 50 mg prescribed for?
Flecainide 50 mg is prescribed to manage and prevent certain supraventricular tachycardias, which are fast heart rhythms originating above the ventricles [2]. This includes conditions like paroxysmal supraventricular tachycardia (PSVT) and the prevention of atrial fibrillation in patients without structural heart disease [3]. The 50 mg dosage is a lower strength, often used as a starting dose or for patients who respond well to smaller amounts of the medication [1][2].
How does flecainide work to control heart rhythm?
Flecainide functions by inhibiting the rapid sodium channels in the heart's cardiac myocytes [2]. This inhibition slows the upstroke of the action potential and increases the effective refractory period. By dampening the electrical signals, flecainide reduces the speed at which electrical impulses travel through the atria and ventricles, thereby preventing rapid, disorganized heart rhythms [2].
What are the potential side effects of flecainide?
Like all medications, flecainide can cause side effects. Common adverse effects include dizziness, headache, nausea, visual disturbances, and fatigue [1]. More serious side effects, though less common, can include new or worsened arrhythmias, heart failure, and conduction abnormalities [2]. Patients with pre-existing heart conditions may be at higher risk for these severe outcomes [2].
When does the patent for flecainide expire?
Flecainide was first approved by the U.S. Food and Drug Administration (FDA) in the early 1980s [4]. As a widely used medication with an established history, its primary patents have long expired, making it available as a generic drug [5]. Information on specific patent expiration dates for the original formulations can be found through resources like DrugPatentWatch.com [5].
Can generic flecainide be used?
Yes, generic versions of flecainide are available and widely used [5]. Generic medications are bioequivalent to their brand-name counterparts, meaning they contain the same active ingredient, dosage form, strength, and route of administration, and are proven to work in the same way [5]. The availability of generics has made treatment more accessible and affordable.
Who manufactures flecainide?
Flecainide is manufactured by various pharmaceutical companies. While the original innovator product may have had specific manufacturers, generic versions are produced by numerous companies worldwide. Specific manufacturers for a given flecainide 50 mg product can be identified by checking product labeling or consulting pharmaceutical databases [1].
What clinical data supports the use of flecainide?
Clinical trials have demonstrated flecainide's efficacy in suppressing supraventricular arrhythmias and preventing atrial fibrillation in selected patient populations [2][3]. However, studies have also highlighted contraindications and risks, particularly in patients with structural heart disease or certain arrhythmias, where flecainide can potentially increase mortality [2]. Guidelines from cardiology societies often detail specific patient selection criteria and monitoring recommendations based on this clinical data [2].
What are the alternatives to flecainide 50 mg?
Alternative treatments for supraventricular tachycardias and atrial fibrillation depend on the specific condition and patient profile. These may include other antiarrhythmic drugs from different classes (e.g., beta-blockers, calcium channel blockers, amiodarone), electrical cardioversion, or catheter ablation [2]. For preventing atrial fibrillation, anticoagulants and rate-controlling medications are also common [3].
What regulatory considerations apply to flecainide?
Flecainide is regulated by health authorities like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) [1][4]. Its use is subject to prescribing information that details indications, contraindications, warnings, precautions, and adverse reactions. Regulatory agencies monitor its safety and efficacy throughout its lifecycle [2].
---
Sources:
[1] Flecainide Acetate, National Institutes of Health, U.S. National Library of Medicine, MedlinePlus. https://medlineplus.gov/druginfo/meds/a682541.html
[2] UpToDate, Flecainide: Drug information.
[3] UpToDate, Treatment of recent-onset atrial fibrillation.
[4] FDA Approved Drug Products, U.S. Food and Drug Administration.
[5] DrugPatentWatch.com